2. Academic Validation
  3. Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)

Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)

  • J Med Chem. 1999 Jan 28;42(2):210-2. doi: 10.1021/jm9806648.
L G Hamann 1,  N S Mani,  R L Davis,  X N Wang,  K B Marschke,  T K Jones
Affiliations

Affiliation

  • 1 Departments of Medicinal Chemistry, Endocrine Research, and New Leads Discovery, Ligand Pharmaceuticals, Inc., 10275 Science Center Drive, San Diego, California 92121, USA. [email protected]
PMID: 9925725 DOI: 10.1021/jm9806648
Figures